KESTINE Coated tablet Ref.[51035] Active ingredients: Ebastine

Source: Web Search  Revision Year: 2007  Publisher: Laboratorios Almirall S.A., Rondo General Mire, 151, 08022 Barcelona, Spain

Product name and form

Kestine 10 mg Tablets.

Pharmaceutical Form

Coated Tablet.

Film-coated, scored, round tablet engraved with E10.

Qualitative and quantitative composition

Each tablet contains Ebastine 10 mg.

For excipients, see section 6.1.

Active Ingredient Description
Ebastine

Ebastine has been shown to produce a rapid and long-lasting inhibition of histamine-induced effect and to have a strong affinity towards H1-receptors.
List of Excipients

Microcrystalline cellulose
Lactose
Pregelatinised maize starch
Croscarmellose sodium
Magnesium stearate
Hypromellose
Macrogol 6000
Titanium dioxide (E171)

Pack sizes and marketing

Boxes containing 1, 3 or 10 PVC aluminium blister cards.

Each blister card contains 10 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Laboratorios Almirall S.A., Rondo General Mire, 151, 08022 Barcelona, Spain

Marketing authorization dates and numbers

PA0968/002/001

Date of first authorisation: 21 July 2000
Date of last renewal: 21 July 2005

Drugs

Drug Countries
KESTINE Estonia, Finland, Italy, Lithuania, Netherlands, Singapore, Turkey, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈